PharMerica (PMC) Tops Q2 EPS by 2c; Rev Guidance Lowered

PharMerica (NYSE: PMC) reported Q2 EPS of $0.32, $0.02 better than the analyst estimate of $0.30. Revenue for the quarter came in at $458.5 million versus the consensus estimate of $488.48 million.

FY12 Revenue Guidance Lowered

For earnings history and earnings-related data on PharMerica (PMC) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• TJX Cos. (TJX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance
• La-Z-Boy (LZB) Misses Q1 EPS by 6c, Misses on Revenue; Offers Weak Q2 Revenue Guidance